• 
  Julien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, Stéphane Barete, Louis Terriou, et al.. Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders. The Journal of Allergy and Clinical Immunology: In Practice, 2022, 10 (5), pp.1356-1364.e2. ⟨10.1016/j.jaip.2021.12.038⟩. ⟨pasteur-03697054⟩
• 
  Ilies Benotmane, Timothée Bruel, Delphine Planas, Samira Fafi-Kremer, Olivier Schwartz, et al.. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients. Kidney International, 2022, 101 (5), pp.1073-1076. ⟨10.1016/j.kint.2022.02.011⟩. ⟨pasteur-03696743⟩
• 
  Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, Olivier Schwartz. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. Journal of Molecular Biology, 2022, 434 (6), pp.167280. ⟨10.1016/j.jmb.2021.167280⟩. ⟨pasteur-03696814⟩
• 
  Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, Timothée Bruel, Pierre Rosenbaum, et al.. Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2. iScience, 2024, 27 (7), pp.110354. ⟨10.1016/j.isci.2024.110354⟩. ⟨pasteur-04645014⟩
• 
  Dania Zhivaki, Sébastien Lemoine, Annick Lim, Ahsen Morva, Pierre-Olivier Vidalain, et al.. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity, 2017, 46 (2), pp.301-314. ⟨10.1016/j.immuni.2017.01.010⟩. ⟨hal-04635836⟩

115

40